PRESS RELEASE published on 02/02/2026 at 07:30, 1 month 24 days ago Carvolix is born and funded French medtech company Affluent Medical rebrands as Carvolix after acquiring Caranx Medical and Artedrone. Completes 10m€ financing with Truffle Capital and Edwards Lifesciences for breakthrough AI-driven mini-robots and biomimetic implants in interventional cardiology and brain stroke treatment. Focus on expanding market and long-term value creation Affluent Medical Carvolix AI-driven Mini-robots Medtech Company Biomimetic Implants
PRESS RELEASE published on 02/02/2026 at 07:30, 1 month 24 days ago Affluent Medical officially becomes CARVOLIX Affluent Medical officially becomes CARVOLIX after completing the acquisitions of CARANX MEDICAL and ARTEDRONE, with a 10m€ first tranche of financing. Carvolix focuses on revolutionizing cardiac valve replacement and brain stroke treatment Innovation Acquisitions Financing Medical Technology Carvolix
BRIEF published on 01/07/2026 at 17:45, 2 months 18 days ago Affluent Medical: Liquidity Contract Review as of December 31, 2025 Liquidity Contract Rothschild Martin Maurel Financial Transactions Securities Traded Medical Afflict
BRIEF published on 01/07/2026 at 17:45, 2 months 18 days ago Affluent Medical : Information sur le capital social et les droits de vote Droits De Vote Capital Social Affluent Medical Implants Innovants Technologies Médicales
BRIEF published on 01/07/2026 at 17:45, 2 months 18 days ago Affluent Medical : Bilan du contrat de liquidité au 31 décembre 2025 Contrat De Liquidité Rothschild Martin Maurel Transactions Financières Affluent Medical Titres Échangés
BRIEF published on 01/07/2026 at 17:45, 2 months 18 days ago Affluent Medical: Information on share capital and voting rights Share Capital Voting Rights Medical Technologies Medical Afflict Innovative Implants
PRESS RELEASE published on 01/07/2026 at 17:40, 2 months 18 days ago Affluent Medical : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.12.25. Affluent Medical publie les nombres d'actions et de droits de vote au 31.12.25 conformément aux règles réglementaires en vigueur. Pour plus d'informations, visitez www.affluentmedical.com Droits De Vote Capital Social Affluent Medical Études Cliniques Technologies Médicales
PRESS RELEASE published on 01/07/2026 at 17:40, 2 months 18 days ago Affluent Medical : Bilan semestriel du contrat de liquidité. Affluent Medical publie son bilan semestriel du contrat de liquidité confié à Rothschild Martin Maurel, incluant les moyens et les transactions. L'entreprise développe des technologies médicales innovantes pour traiter les maladies cardiaques et l'incontinence urinaire Contrat De Liquidité Affluent Medical Maladies Cardiaques Incontinence Urinaire Technologies Médicales
BRIEF published on 01/05/2026 at 17:50, 2 months 20 days ago Affluent Medical: Share and voting rights status as of November 30, 2025 Euronext Paris Share Capital Voting Rights AMF Regulations Medical Afflict
BRIEF published on 01/05/2026 at 17:50, 2 months 20 days ago Affluent Medical : Statut des actions et droits de vote au 30 novembre 2025 Euronext Paris Droits De Vote Capital Social Affluent Medical Réglementation AMF
Published on 03/26/2026 at 13:00, 3 hours 24 minutes ago Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 13:00, 3 hours 24 minutes ago GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle
Published on 03/26/2026 at 12:59, 3 hours 25 minutes ago Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance
Published on 03/26/2026 at 12:45, 3 hours 39 minutes ago Quartz Mountain Reports Strong Warrant Exercise Participation and Provides Exploration Update at Maestro Project, Central British Columbia
Published on 03/26/2026 at 15:25, 59 minutes ago Duck Creek Loss Control Named 2026 Insurance Luminary Finalist by PropertyCasualty360
Published on 03/26/2026 at 15:23, 1 hour ago Sartorius AG - Resolutions of the Annual General Meeting
Published on 03/26/2026 at 15:05, 1 hour 19 minutes ago JOY GROUP Announces 2025 Financial Results, Revenue Surpasses US$620M
Published on 03/26/2026 at 15:01, 1 hour 22 minutes ago EQS-Adhoc: CENIT AG decides to switch from the Regulated Market (Prime Standard) to the Scale Segment of the Frankfurt Stock Exchange
Published on 03/26/2026 at 15:00, 1 hour 24 minutes ago OLB’s financial performance remains at a consistently high level
Published on 03/26/2026 at 07:30, 8 hours 54 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/26/2026 at 07:30, 8 hours 54 minutes ago BIOPHYTIS ET LYNXKITE INVITÉS À LA CONFÉRENCE NVIDIA : L’IA AU SERVICE DE LA LONGÉVITÉ
Published on 03/25/2026 at 18:53, 21 hours 30 minutes ago CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026